Can an Anti-Aging Pill Stop Aging? | Grape Seed Science
A Chinese startup claims its new grape-seed extract pill could push human longevity to a record-breaking 150 years by purging inflammatory “zombie cells.”
Lonvi Biosciences, a startup based in Shenzhen, is making headlines with its development of a potential anti-aging treatment centered on a compound called Procyanidin C1 (PCC1). Extracted from grape seeds, PCC1 targets “zombie cells”—senescent cells that no longer divide but linger in the body, causing chronic inflammation and driving age-related decline. In animal trials, researchers reported that the compound increased the overall lifespan of mice by nearly 10%, with some late-life interventions showing survival boosts of up to 64%. Company leadership has described the pursuit of this treatment as the “Holy Grail” of longevity science, aiming to fundamentally alter the human biological clock.
Despite the ambitious goal of extending human life to 150 years, the global scientific community maintains a healthy dose of skepticism. While the results in rodent models are statistically significant, these effects have not yet been confirmed through human clinical trials, and the biological leap from mice to humans is notoriously complex. Experts emphasize that while China’s longevity sector is expanding at a rapid pace, a pill capable of nearly doubling current life expectancy is not yet a proven reality. For now, the prospect of a 150-year lifespan remains a speculative frontier in the ongoing race to conquer the diseases of aging.
source: Lonvi Biosciences. (2024). Research and Development of Procyanidin C1 for Senescent Cell Management and Lifespan Extension. Shenzhen, China.
